Copyright held by the owner/author(s).

Public health groups and individual scientists together sued the NIH over the discontinuation of hundreds of research grants worth more than $2.4 billion. The lawsuit, filed by NIH-funded scientists ...

1Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license This work ...

1Department of Pediatric Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts. *Corresponding Author: Junne Kamihara, Department of ...

1Center for Clinical Research and Translational Medicine, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, China. 2Department of General Surgery, Yangpu Hospital, School of Medicine, ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

*Corresponding Author: Ravi Bhatia, Division of Hematology/Oncology, Department of Medicine, The University of Alabama at Birmingham, 1802 6th Avenue, South, North Pavilion, Room 2555C, Birmingham, AL ...

Cancer Discov (2025) 15 (4): 673–677. Here, we discuss the seven new challenges set by Cancer Grand Challenges that are currently open for creative applications. We invite the research community to ...

1Department of Pathology, The University of Chicago, Chicago, Illinois. 2Department of Medicine, The University of Chicago, Chicago, Illinois. Search for other works by this author on: 1Department of ...

1Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania. 2The Melanoma and Skin Cancer Center, The Pennsylvania State University College of Medicine, ...

Major Finding: A cancer-associated fibroblast (CAF)–epithelial cell niche shields squamous cell carcinomas (SCC) from antitumor immune responses. Concept: Epithelial JAG1–NOTCH1 signaling promotes the ...